APO RESEARCH · REPORT
Methotrexate
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Product & engineering
Understand the product.
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
Selected research
Industry Research
Methotrexate Industry Research Report 2026
Market perspective
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.
Read the full market overview
The key players are Teva Pharmaceutical Industries, Qualitestrx(DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu etc. Top 3 companies occupied about 65% market share.
Report Scope
This report quantifies the global Methotrexate market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Methotrexate Market by Company
Teva Pharmaceutical Industries
Qualitestrx (DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu
Methotrexate Segment by Type
Methotrexate for Injection
Methotrexate Tablets
Methotrexate Segment by Application
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
Methotrexate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methotrexate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Methotrexate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methotrexate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Methotrexate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Methotrexate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Methotrexate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Methotrexate for Injection
- Methotrexate Tablets
Applications
- Used for Cancers
- Used for Rheumatoid Arthritis
- Used for Other Diseases
Companies covered
- Teva Pharmaceutical Industries
- Qualitestrx (DAVA Pharmaceuticals)
- Pfizer (Hospira)
- Roxane Laboratories
- Sine
- Maoxiang
- LingNan Pharmaceutical
- Powerdone
- Huiyu
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Methotrexate Market Size (2021-2032)
- 2.2.2 Global Methotrexate Sales (2021-2032)
- 2.2.3 Global Methotrexate Market Average Price (2021-2032)
- 2.3 Methotrexate by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Methotrexate for Injection
- 2.3.3 Methotrexate Tablets
- 2.4 Methotrexate by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Used for Cancers
- 2.4.3 Used for Rheumatoid Arthritis
- 2.4.4 Used for Other Diseases
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Methotrexate Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Methotrexate Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Methotrexate Revenue of Manufacturers (2021-2026)
- 3.4 Global Methotrexate Average Price by Manufacturers (2021-2026)
- 3.5 Global Methotrexate Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Methotrexate, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Methotrexate, Product Type & Application
- 3.8 Global Manufacturers of Methotrexate, Established Date
- 3.9 Global Methotrexate Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical Industries
- 4.1.1 Teva Pharmaceutical Industries Company Information
- 4.1.2 Teva Pharmaceutical Industries Business Overview
- 4.1.3 Teva Pharmaceutical Industries Methotrexate Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Industries Methotrexate Product Portfolio
- 4.1.5 Teva Pharmaceutical Industries Recent Developments
- 4.2 Qualitestrx (DAVA Pharmaceuticals)
- 4.2.1 Qualitestrx (DAVA Pharmaceuticals) Company Information
- 4.2.2 Qualitestrx (DAVA Pharmaceuticals) Business Overview
- 4.2.3 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Product Portfolio
- 4.2.5 Qualitestrx (DAVA Pharmaceuticals) Recent Developments
- 4.3 Pfizer (Hospira)
- 4.3.1 Pfizer (Hospira) Company Information
- 4.3.2 Pfizer (Hospira) Business Overview
- 4.3.3 Pfizer (Hospira) Methotrexate Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer (Hospira) Methotrexate Product Portfolio
- 4.3.5 Pfizer (Hospira) Recent Developments
- 4.4 Roxane Laboratories
- 4.4.1 Roxane Laboratories Company Information
- 4.4.2 Roxane Laboratories Business Overview
- 4.4.3 Roxane Laboratories Methotrexate Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Roxane Laboratories Methotrexate Product Portfolio
- 4.4.5 Roxane Laboratories Recent Developments
- 4.5 Sine
- 4.5.1 Sine Company Information
- 4.5.2 Sine Business Overview
- 4.5.3 Sine Methotrexate Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sine Methotrexate Product Portfolio
- 4.5.5 Sine Recent Developments
- 4.6 Maoxiang
- 4.6.1 Maoxiang Company Information
- 4.6.2 Maoxiang Business Overview
- 4.6.3 Maoxiang Methotrexate Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Maoxiang Methotrexate Product Portfolio
- 4.6.5 Maoxiang Recent Developments
- 4.7 LingNan Pharmaceutical
- 4.7.1 LingNan Pharmaceutical Company Information
- 4.7.2 LingNan Pharmaceutical Business Overview
- 4.7.3 LingNan Pharmaceutical Methotrexate Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 LingNan Pharmaceutical Methotrexate Product Portfolio
- 4.7.5 LingNan Pharmaceutical Recent Developments
- 4.8 Powerdone
- 4.8.1 Powerdone Company Information
- 4.8.2 Powerdone Business Overview
- 4.8.3 Powerdone Methotrexate Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Powerdone Methotrexate Product Portfolio
- 4.8.5 Powerdone Recent Developments
- 4.9 Huiyu
- 4.9.1 Huiyu Company Information
- 4.9.2 Huiyu Business Overview
- 4.9.3 Huiyu Methotrexate Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Huiyu Methotrexate Product Portfolio
- 4.9.5 Huiyu Recent Developments
5 Global Methotrexate Market Scenario by Region
- 5.1 Global Methotrexate Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Methotrexate Sales by Region: 2021-2032
- 5.2.1 Global Methotrexate Sales by Region: 2021-2026
- 5.2.2 Global Methotrexate Sales by Region: 2027-2032
- 5.3 Global Methotrexate Revenue by Region: 2021-2032
- 5.3.1 Global Methotrexate Revenue by Region: 2021-2026
- 5.3.2 Global Methotrexate Revenue by Region: 2027-2032
- 5.4 North America Methotrexate Market Facts & Figures by Country
- 5.4.1 North America Methotrexate Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Methotrexate Sales by Country (2021-2032)
- 5.4.3 North America Methotrexate Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Methotrexate Market Facts & Figures by Country
- 5.5.1 Europe Methotrexate Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Methotrexate Sales by Country (2021-2032)
- 5.5.3 Europe Methotrexate Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Methotrexate Market Facts & Figures by Country
- 5.6.1 Asia Pacific Methotrexate Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Methotrexate Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Methotrexate Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Methotrexate Market Facts & Figures by Country
- 5.7.1 South America Methotrexate Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Methotrexate Sales by Country (2021-2032)
- 5.7.3 South America Methotrexate Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Methotrexate Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Methotrexate Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Methotrexate Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Methotrexate Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Methotrexate Sales by Type (2021-2032)
- 6.1.1 Global Methotrexate Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Methotrexate Sales Market Share by Type (2021-2032)
- 6.2 Global Methotrexate Revenue by Type (2021-2032)
- 6.2.1 Global Methotrexate Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Methotrexate Revenue Market Share by Type (2021-2032)
- 6.3 Global Methotrexate Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Methotrexate Sales by Application (2021-2032)
- 7.1.1 Global Methotrexate Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Methotrexate Sales Market Share by Application (2021-2032)
- 7.2 Global Methotrexate Revenue by Application (2021-2032)
- 7.2.1 Global Methotrexate Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Methotrexate Revenue Market Share by Application (2021-2032)
- 7.3 Global Methotrexate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Methotrexate Value Chain Analysis
- 8.1.1 Methotrexate Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Methotrexate Production Mode & Process
- 8.2 Methotrexate Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Methotrexate Distributors
- 8.2.3 Methotrexate Customers
9 Global Methotrexate Analyzing Market Dynamics
- 9.1 Methotrexate Industry Trends
- 9.2 Methotrexate Industry Drivers
- 9.3 Methotrexate Industry Opportunities and Challenges
- 9.4 Methotrexate Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst